High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

BACKGROUND: Acute myeloid leukemia (AML) is a highly heterogeneous malignancy with various outcomes, and therefore needs better risk stratification tools to help select optimal therapeutic options. METHODS: In this study, we identify miRNAs that could predict clinical outcome in a heterogeneous AML...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huihui, Zhang, Ninghan, Wang, Rong, Shao, Tingting, Feng, Yuan, Yao, Yao, Wu, Qingyun, Zhu, Shengyun, Cao, Jiang, Zhang, Huanxin, Li, Zhenyu, Liu, Xuejiao, Niu, Mingshan, Xu, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444823/
https://www.ncbi.nlm.nih.gov/pubmed/30935386
http://dx.doi.org/10.1186/s12967-019-1858-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444823/
https://www.ncbi.nlm.nih.gov/pubmed/30935386
http://dx.doi.org/10.1186/s12967-019-1858-7

Ejemplares similares